Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (851-860 of 903) with videos related to

Pageof 91
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2015
The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune CellsSara E Martin del Campo, Kala M Levine, Bethany L Mundy-Bosse, et al.
Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in OncologyWilliam G Wierda, John C Byrd, Jeremy S Abramson, et al.
Cancer Immunology Research|February 12, 2016
NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by CytokinesAlena C Jaime-Ramirez, Elizabeth McMichael, SriVidya Kondadasula, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019William G Wierda, John C Byrd, Jeremy S Abramson, et al.
The New England Journal of Medicine|December 8, 2015
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic LeukemiaJohn C Byrd, Bonnie Harrington, Susan O'Brien, et al.
Haematologica|August 8, 2024
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemiaJanani Ravikrishnan, Daisy Y Diaz-Rohena, Elizabeth Muhowski, et al.
JCI Insight|February 23, 2026
Characterization of the clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Chia Sharpe, Kate Quinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene scoreGuido Marcucci, Pearlly Yan, Kati Maharry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2024
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective StudyAdam S Kittai, David Bond, Ying Huang, et al.
Pageof 91

Showing results (851-860 of 903) with videos related to

Sort By:
Pageof 91
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2015
The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune CellsSara E Martin del Campo, Kala M Levine, Bethany L Mundy-Bosse, et al.
Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in OncologyWilliam G Wierda, John C Byrd, Jeremy S Abramson, et al.
Cancer Immunology Research|February 12, 2016
NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by CytokinesAlena C Jaime-Ramirez, Elizabeth McMichael, SriVidya Kondadasula, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019William G Wierda, John C Byrd, Jeremy S Abramson, et al.
The New England Journal of Medicine|December 8, 2015
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic LeukemiaJohn C Byrd, Bonnie Harrington, Susan O'Brien, et al.
Haematologica|August 8, 2024
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemiaJanani Ravikrishnan, Daisy Y Diaz-Rohena, Elizabeth Muhowski, et al.
JCI Insight|February 23, 2026
Characterization of the clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Chia Sharpe, Kate Quinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene scoreGuido Marcucci, Pearlly Yan, Kati Maharry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2024
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective StudyAdam S Kittai, David Bond, Ying Huang, et al.
Pageof 91